Cargando…

Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance

BACKGROUND: Genetic heterogeneity is common in inherited cardiac diseases. Next-generation sequencing gene panels are therefore suitable for genetic diagnosis. We describe the results of implementation of cardiomyopathy and arrhythmia gene panels in clinical care. METHODS: We present detection rates...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Lint, F. H. M., Mook, O. R. F., Alders, M., Bikker, H., Lekanne dit Deprez, R. H., Christiaans, I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533346/ https://www.ncbi.nlm.nih.gov/pubmed/30847666 http://dx.doi.org/10.1007/s12471-019-1250-5

Ejemplares similares

Large next-generation sequencing gene panels in genetic heart disease: challenges in clinical practice
por: Christiaans, I., et al.
Publicado: (2019)

Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes
por: Mazzaccara, Cristina, et al.
Publicado: (2022)

Are DDX41 variants of unknown significance and pathogenic variants created equal?
por: Xie, Zhuoer, et al.
Publicado: (2023)

Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance
por: Hoppe, Kerstin, et al.
Publicado: (2021)

Computational and biophysical determination of pathogenicity of variants of unknown significance in cardiac thin filament
por: Mason, Allison B., et al.
Publicado: (2021)

Clinical significance of variants of unknown significances in BRCA genes
por: Choi, Min Chul
Publicado: (2019)

Removing uncertainty from variants of unknown significance
por: McNally, Elizabeth M.
Publicado: (2023)

Terminal osseous dysplasia with pigmentary defects and cardiomyopathy caused by a novel FLNA variant
por: Rumping, Lynne, et al.
Publicado: (2021)

The Clinical Significance of Unknown Sequence Variants in BRCA Genes
por: Calò, Valentina, et al.
Publicado: (2010)

Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test
por: Harada, Yohei, et al.
Publicado: (2022)

Actionability classification of variants of unknown significance correlates with functional effect
por: Johnson, Amber, et al.
Publicado: (2023)

Feasibility of Follow-Up Studies and Reclassification in Spinocerebellar Ataxia Gene Variants of Unknown Significance
por: Ghorbani, Fatemeh, et al.
Publicado: (2022)

Systematic analysis of PINK1 variants of unknown significance shows intact mitophagy function for most variants
por: Ma, Kai Yu, et al.
Publicado: (2021)

Predicting Ovarian/Breast Cancer Pathogenic Risks of Human BRCA1 Gene Variants of Unknown Significance
por: Lin, Hui-Heng, et al.
Publicado: (2021)

Computational and experimental methods for classifying variants of unknown clinical significance
por: Spielmann, Malte, et al.
Publicado: (2022)

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
por: Susswein, Lisa R., et al.
Publicado: (2016)

From variant of unknown significance to likely pathogenic: Characterization and pathogenicity determination of a large genomic deletion in the MLH1 gene
por: Bouras, Ahmed, et al.
Publicado: (2023)

Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine
por: De Paolis, Elisa, et al.
Publicado: (2023)

BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status
por: Jansen, M., et al.
Publicado: (2021)

The known unknown: the challenges of genetic variants of uncertain significance in clinical practice
por: Hoffman-Andrews, Lily
Publicado: (2018)

Characterizing variants of unknown significance in rhodopsin: A functional genomics approach
por: Wan, Aliete, et al.
Publicado: (2019)

High-throughput functional evaluation of BRCA2 variants of unknown significance
por: Ikegami, Masachika, et al.
Publicado: (2020)

Hereditary variants of unknown significance in African American women with breast cancer
por: McDonald, J. Tyson, et al.
Publicado: (2022)

Targeted sequence capture and GS-FLX Titanium sequencing of 23 hypertrophic and dilated cardiomyopathy genes: implementation into diagnostics
por: Mook, Olaf R F, et al.
Publicado: (2013)

Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel
por: AlHarbi, Musa, et al.
Publicado: (2023)

Biochemical Studies in Fibroblasts to Interpret Variants of Unknown Significance in the ABCD1 Gene
por: van de Stadt, Stephanie I. W., et al.
Publicado: (2021)

Variants of Uncertain Significance and “Missing Pathogenicity”
por: Fatkin, Diane, et al.
Publicado: (2020)

Diagnostic Yield of Next-Generation Sequencing in Patients With Chronic Kidney Disease of Unknown Etiology
por: de Haan, Amber, et al.
Publicado: (2019)

The Relevance of Variants With Unknown Significance for Autism Spectrum Disorder Considering the Genotype–Phenotype Interrelationship
por: Lovato, Diogo V., et al.
Publicado: (2019)

Upgrading an intronic TMEM67 variant of unknown significance to likely pathogenic through RNA studies and community data sharing
por: Kurolap, Alina, et al.
Publicado: (2022)

Unknown variant of the accessory subscapularis muscle?
por: Zielinska, Nicol, et al.
Publicado: (2021)

The influence of BRCA variants of unknown significance on cancer risk management decision-making
por: Chern, Jing-Yi, et al.
Publicado: (2019)

A functional assay to classify ZBTB24 missense variants of unknown significance
por: Wu, Haoyu, et al.
Publicado: (2019)

Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
por: Hsu, Simon, et al.
Publicado: (2020)

Characterizing Variants of Unknown Significance of the PTEN tumour suppressorHomolog DAF-18
por: Ermakova, Glafira, et al.
Publicado: (2022)

Utilizing ExAC to assess the hidden contribution of variants of unknown significance to Sanfilippo Type B incidence
por: Clark, Wyatt T., et al.
Publicado: (2018)

Correction: Corrigendum: Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Publicado: (2016)

BRCA1 and BRCA2 Testing through Next Generation Sequencing in a Small Cohort of Italian Breast/Ovarian Cancer Patients: Novel Pathogenic and Unknown Clinical Significance Variants
por: Concolino, Paola, et al.
Publicado: (2019)

Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas
por: Shin, Hyemi, et al.
Publicado: (2020)

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants
por: Jansen, Mark, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jeqvrm207p4a2s5tmbogfa20tr